Walleye Capital
IRMD icon

Walleye Capital’s iRadimed IRMD Stock Holding History

Walleye Capital’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,832
Closed -$211K – 4662
2024
Q4 		$211K Sell
3,832
-3,345
-47% -$176K ﹤0.01% 3718
2024
Q3 		$361K Buy
+7,177
New +$331K ﹤0.01% 3585
2023
Q4 		– Sell
-5,128
Closed -$228K – 5218
2023
Q3 		$228K Buy
+5,128
New +$238K ﹤0.01% 3454

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital's IRMD Position: Q1 2025 in Review

Walleye Capital sold out of iRadimed (IRMD) in Q1 2025, closing a stake of 3,832 shares — an estimated $211K sold.

Walleye Capital first reported a position in IRMD in Q3 2023 and held it in 3 quarters. The position peaked at $361K in Q3 2024. 168 funds tracked by Wall St. Rank hold IRMD as of Q1 2025.

  • Walleye Capital reported no remaining iRadimed position as of Q1 2025 after selling out during the quarter.
  • Walleye Capital sold 3,832 iRadimed shares in Q1 2025, an estimated $211K.
  • Walleye Capital first reported a position in iRadimed in Q3 2023 and held it in 3 quarters.
  • Walleye Capital's iRadimed position peaked at $361K in Q3 2024.
  • 168 funds tracked by Wall St. Rank held iRadimed as of Q1 2025.

Based on Walleye Capital's 13F filing for Q1 2025, filed 14 May 2025.